1,2,4-triazine has been researched along with Anasarca in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Edraki, N; Firuzi, O; Foroumadi, A; Ghahremani, MH; Khoshneviszadeh, M; Madadkar-Sobhani, A; Miri, R; Parsa, M; Shafiee, A | 1 |
Amini, M; Assadieskandar, A; Irannejad, H; Kebriaieezadeh, A; Montazer-Sadegh, F; Shafiee, A; Zarghi, A | 1 |
2 other study(ies) available for 1,2,4-triazine and Anasarca
Article | Year |
---|---|
Design, synthesis and biological evaluation of novel anti-cytokine 1,2,4-triazine derivatives.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Carrageenan; Cell Survival; Cells, Cultured; Drug Design; Edema; Humans; Hydrazones; Interleukin-1beta; Leukocytes, Mononuclear; MCF-7 Cells; Molecular Docking Simulation; p38 Mitogen-Activated Protein Kinases; Protein Structure, Tertiary; Rats; Signal Transduction; Structure-Activity Relationship; Triazines; Tumor Necrosis Factor-alpha | 2013 |
Synthesis, docking simulation, biological evaluations and 3D-QSAR study of 5-Aryl-6-(4-methylsulfonyl)-3-(metylthio)-1,2,4-triazine as selective cyclooxygenase-2 inhibitors.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Edema; Male; Mice; Molecular Docking Simulation; Molecular Structure; Quantitative Structure-Activity Relationship; Rats; Triazines | 2014 |